Taro Pharmaceutical Industries Ltd (NYSE:TARO)

76.03
Delayed Data
As of Oct 17
 +0.27 / +0.36%
Today’s Change
72.97
Today|||52-Week Range
109.42
-10.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Operating ActivitiesNet Income / Starting Line541.3M456.7M210.1M282.1M
 
 
 
 
 
Depreciation14.8M14.8M16.5M18.6M
 
 
 
 
 
Total Other Cash Flow-11.9M-27.6M33.4M-26.4M
 
 
 
 
 
Funds From Operations532.3M517.6M316.0M286.6M
 
 
 
 
 
Funds From/For Other Operating Expenses137.2M80.1M-7.7M-37.2M
 
 
 
 
 
Net Cash Flow - Operating Activities395.1M437.5M323.7M323.8M
 
 
 
 
 
 
InvestingIncrease In Investments-220.2M---1.1B-1.2B
 
 
 
 
Decrease In Investments--196.1M531.4M1.5B
 
 
 
 
Capital Expenditures-19.0M-35.8M-26.9M-27.0M
 
 
 
 
 
Fixed Asset Disposal0.008.5M1.1M0.00
 
 
 
Other Investing - Uses-80.6M-286.6M--0.00
 
 
 
Other Investing - Sources35.0M10.0K396.3M0.00
 
 
 
 
Net Cash Flow Investing-284.9M-117.8M-241.6M257.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-5.9M0.000.000.00
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-9.5M-294.9M-107.0M-88.8M
 
 
 
 
 
Common Dividends0.000.000.00-500.0M
 
 
Cash Dividends Paid - Total0.000.000.00-500.0M
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-15.3M-294.9M-107.0M-588.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash57.0K-1.2M1.1M-1.2M
 
 
 
 
 
 
Net Change In Cash94.9M24.9M-24.9M-7.9M